Gregory L. Smith - 31 Jul 2025 Form 4 Insider Report for Medtronic plc (MDT)

Reporting relationship
EVP Global Ops & Supply Chain
Issuer ticker
MDT
Reported as of
31 Jul 2025
Net transaction value
-$147,091
Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
01 Aug 2025, 13:10:39 UTC
Prior SEC filing
30 Jul 2025
Next SEC filing
04 Aug 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Patricia Walesiewicz, attorney-in-fact

Key filing fact

Gregory L. Smith filed Form 4 for Medtronic plc (MDT) on 01 Aug 2025.

Key facts

  • This page summarizes Gregory L. Smith's Form 4 filing for Medtronic plc (MDT).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 01 Aug 2025, 13:10.

Change

  • Previous filing in this sequence was filed on 30 Jul 2025.
  • Current net transaction value: -$147,091.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001533098 Primary reporting owner

Smith Gregory L

Relationship
EVP Global Ops & Supply Chain
Address
710 MEDTRONIC PARKWAY, MINNEAPOLIS
Signature
/s/ Patricia Walesiewicz, attorney-in-fact
Signature date
01 Aug 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

MDT transaction

Ordinary Shares

Tax liability

Transaction value
$147,091
Shares
-1,630
Change %
-2.2%
Price
$90.24
Shares after
71,743
Date
31 Jul 2025
Ownership
Direct
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Represents shares withheld for payment of taxes upon the vesting of restricted stock units previously reported on Table I.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .